Page last updated: 2024-09-05

2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Carcinoma, Ductal, Breast

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alaoui-Jamali, MA; Bijian, K; Lougheed, C; Riccio, K; Su, J; Wu, JH; Xu, B; Yu, H1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Carcinoma, Ductal, Breast

ArticleYear
Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine.
    British journal of cancer, 2013, Nov-26, Volume: 109, Issue:11

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cells, Cultured; Female; Focal Adhesions; Humans; MCF-7 Cells; Mice; Mice, SCID; Molecular Targeted Therapy; Morpholines; Purines; Xenograft Model Antitumor Assays

2013